On May 24, Northbrook, Ill.-headquartered UMF|PerfectCLEAN announced via a press release that Klorese disinfectant is now EPA-registered for reduced contact time against more than 20 pathogens, including Candida auris (C. auris) fungus.
According to the CDC, C. auris kills one in three patients within a month of diagnosis. Klorese kills C. auris in two minutes and is registered on all 14 EPA lists covering disinfectants. Klorse also holds a soft surface pathogen claim—meaning that it can assist in preventing cross contamination from cubicle curtains and other textiles found in healthcare settings.
The press release states that “The Centers for Disease Control and Prevention (CDC) reports that C. auris, an emerging fungus considered an urgent antimicrobial resistance (AR) threat, spread at an alarming rate in U.S. healthcare facilities from 2020 to 2021. C. auris case counts likely increased for many reasons, including a strain on healthcare and public health systems during the pandemic and resulting poor general infection prevention and control practices in healthcare facilities.”
Further, “C. auris is concerning because it is often multidrug-resistant; it is difficult to identify with standard laboratory methods; it has caused outbreaks in healthcare settings; and it is a yeast capable of producing biofilm, which protects pathogens from many disinfectants.”
UMF|PerfectCLEAN CEO George Clarke was quoted in the release saying that "If you are not disinfecting patient care environments for biofilm, then you are not disinfecting."
